Abstract CT066: Phase 1 Study of MDM2 Antagonist ASTX295 in Patients with Solid Tumors with Wild-Type TP53
Ecaterina E. Dumbrava, Fabio M. Iwamoto,Mark Agulnik,Mohammed Milhem,Anthony W. Tolcher,Rashmi Chugh,Michael J. Demeure,Alain Mita, Kurt Demel,Mark Diamond,Beloo Mirakhur, Laksmi Wilson,Aram Oganesian,Danna Chan,Harold N. Keer,Jason Taylor,Martin J. Sims,Andrea Biondo,Simone Jueliger,Alexander Spira CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
